AJJ Medtech Holdings Limited Stock: price and insider trades · Singapore
No insider purchase over the last 90 days. The latest, by Chong Eng Wee, was filed 13 Nov 2025.
AJJ Medtech Holdings Limited: what insiders have been doing
AJJ Medtech Holdings Limited is a listed company. Filings by its managers are published through SGX. Between 20 October 2025 and 20 October 2026, 5 insiders published 6 filings.
Both sides are active: 4 purchases and 1 sale, from 4 insiders and 1 insider respectively. The amount is not disclosed for 5 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 4 chief executives among the declarants.
For context, the typical company on the same exchange (median of 393 companies) published 6 filings over the same period, against 6 filings here. Looking back to 2017, when coverage begins, insiders filed 12 purchases and 2 sales.
The clock since the last published purchase (13 November 2025) now reads 360 days. Between a trade and the moment it shows up on SGX, the median delay is 6 days. This delay matters because a trade only becomes useful information once it is public.
This summary is built from SGX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -66.7%Entry SGD 0.01 · Close at T+365 SGD 0.00
- -60.0%Entry SGD 0.00 · Close at T+365 SGD 0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 50,000,000 sharesShareSGX-STISIN SG0584008601SGX:CO76QPWDZ491FSN2
- 1,200,000 sharesShareSGX-STISIN SG0584008601SGX:DRR9VEKY9SNB79KKCanonical exit: 5 Feb 2026 (T+90)
- 1,000,000 sharesShareSGX-STISIN SG0584008601SGX:BTWTEROFNOWXLKGUCanonical exit: 5 Feb 2026 (T+90)
- 1,000,000 sharesShareSGX-STISIN SG0584008601SGX:KGARDL1MMO3Z1XC4Canonical exit: 5 Feb 2026 (T+90)
- ShareSGX-STISIN SG0584008601SGX:G1CXB4BOEU66EP2P
- 8,000,000 sharesShareSGX-STISIN SG0584008601SGX:TD45G3QMUNWJ4NV5Canonical exit: 5 Feb 2026 (T+90)
- 18,000,000 sharesShareSGX-STISIN SG0584008601SGX:ZSWPN4GTFOZCFNVDCanonical exit: 10 Nov 2024 (T+90)
- 78,000,000 sharesShareSGX-STISIN SG0584008601SGX:877PNC4SS79MECSWCanonical exit: 10 Nov 2024 (T+90)
- 1,700,000 sharesShareSGX-STISIN SG0584008601SGX:SZ1AC3TY317KB9GWCanonical exit: 17 Sept 2024 (T+90)
- 1,700,000 sharesShareSGX-STISIN SG0584008601SGX:50WORL8M4NPEBMBUCanonical exit: 17 Sept 2024 (T+90)
- 2,100,000 sharesShareSGX-STISIN SG0584008601SGX:0PLB2WU23VI83A59Canonical exit: 17 Sept 2024 (T+90)
- ShareSGX-STISIN SG0584008601SGX:QDGXBABL2M1UETRF
- ShareSGX-STISIN SG0584008601SGX:OWGWMSBNIRBYXVZF
- 87,428,571 shares@ SGD 0.0057100.0% of flowShareSGX-STISIN SG0584008601SGX:7RAJP61U9J9ZGZ62Canonical exit: 10 Jun 2024 (T+90)
- 145,285,714 shares@ SGD 0.007100.0% of flowShareSGX-STISIN SG0584008601SGX:JB22TGPGDOAZYDN7Canonical exit: 3 Jun 2024 (T+90)
- ShareSGX-STISIN SG0584008601SGX:PR4TQSVX6WJ9RE8F
- ShareSGX-STISIN SG0584008601SGX:B4X582822BYHL2SI
- 138,331,000 shares@ SGD 0.030650.1% of flowShareSGX-STISIN SG0584008601SGX:F7EBLPACUIPGDAY8
- 186,853,000 shares@ SGD 0.0306100.0% of flowShareSGX-STISIN SG0584008601SGX:3GY8Q1P825GYHIDH
- 138,331,000 shares@ SGD 0.030649.9% of flowShareSGX-STISIN SG0584008601SGX:SXX7CP816LFM565ICanonical exit: 19 Mar 2020 (T+90)
- ShareSGX-STISIN SG0584008601SGX:MVD56OR2MOZHVRGY
- ShareSGX-STISIN SG0584008601SGX:7KY1KUN0OAKIPUOB
- ShareSGX-STISIN SG0584008601SGX:ONPAWMHJ9HKU09QJ
23 of 23 declarations
About AJJ Medtech Holdings Limited
AJJ Medtech Holdings Limited is a company listed on the XSES exchange, specializing in the medical technology sector. It focuses on the development and commercialization of innovative solutions for the healthcare industry.